vaccine for children

DCGI panel to review on Friday SII applications for Covovax's use among kids aged 2-7 yrs, 7-11 yrs

New Delhi, June 23 (PTI) The subject expert committee on COVID-19 of India's drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorisation to use